TIMOTHY MITZEL: Open Payments
NPI 1285656785 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$345 in 19 payments from 8 companies in 2025. Trend: 2023 $416 · 2024 $470 · 2025 $345
Food & beverage: $345
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $76 |
| Vanda Pharmaceuticals Inc. | 4 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $49 |
| Lundbeck LLC | 2 | $34 |
| Alkermes, Inc. | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: REXULTI, TRINTELLIX, CAPLYTA, HETLIOZ, FANAPT, LYBALVI, SPRAVATO, Auvelity.
Industry payments across PA — which companies pay providers there.
